Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 04/09/2007
Entire Document
 
 

     IN WITNESS WHEREOF, the parties have executed this Right of First Refusal and Co-Sale Agreement as of the date first written above.
INVESTORS:
Sofinnova Venture Partners VI, L.P.
as nominee for
Sofinnova Venture Partners VI, L.P.
Sofinnova Venture Partners VI GmbH & Co. K.G.
By: Sofinnova Management VI, L.L.C.
       its General Partner
         
  By:      
    Managing Member   
       
 
SIGNATURE PAGE TO RIGHT OF FIRST REFUSAL AND
CO-SALE AGREEMENT